Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$702K Buy
170,000
+82,500
+94% +$364K 0.04% 249
2026
Q1
$316K Sell
87,500
-12,500
-13% -$43.2K 0.02% 323
2025
Q4
$341K Sell
100,000
-20,000
-17% -$97.1K 0.02% 310
2025
Q3
$815K Hold
120,000
0.05% 231
2025
Q2
$1.63M Hold
120,000
0.1% 174
2025
Q1
$653K Buy
+120,000
New +$681K 0.04% 240

Other funds holding LFMD

Courier Capital's LFMD Position: Q2 2026 in Review

Courier Capital increased its LifeMD (LFMD) stake by 94% in Q2 2026, buying an estimated $364K and bringing the position to 170,000 shares worth $702K. The position accounts for 0.04% of the portfolio, ranked #249.

Courier Capital first reported a position in LFMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.63M in Q2 2025. 20 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Courier Capital held 170,000 shares of LifeMD worth $702K as of Q2 2026.
  • Courier Capital bought 82,500 LifeMD shares in Q2 2026, an estimated $364K.
  • LifeMD made up 0.04% of Courier Capital's portfolio in Q2 2026, its #249 holding.
  • Courier Capital first reported a position in LifeMD in Q1 2025 and has held it in 6 quarters since.
  • Courier Capital's LifeMD position peaked at $1.63M in Q2 2025.
  • 20 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.